These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 682381)

  • 1. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
    Chinzei H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the improvement of treatment of Habu (Trimeresurus flavoviridis) bites. 9. Studies on the immunogenicity of the purified Habu venom toxoid by alcohol precipitation.
    Sawai Y; Chinzei H; Kawamura Y; Fukuyama T; Okonogi T
    Jpn J Exp Med; 1972 Apr; 42(2):155-64. PubMed ID: 4537796
    [No Abstract]   [Full Text] [Related]  

  • 3. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic biology tackles global antivenom shortage.
    Arnold C
    Nature; 2016 Apr; 532(7599):292. PubMed ID: 27111610
    [No Abstract]   [Full Text] [Related]  

  • 5. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological studies on monovalent Enhydrina schistosa antivenin.
    Gawade SP; Gaitonde BB
    Indian J Med Res; 1980 Dec; 72():895-900. PubMed ID: 7228199
    [No Abstract]   [Full Text] [Related]  

  • 7. Snake envenomation.
    Aggarwal R; Thavaraj V
    Indian Pediatr; 1994 Oct; 31(10):1309-13. PubMed ID: 7875805
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the improvement of treatment of habu (Trimeresurus flavoviridis) bites. 7. Experimental studies on the habu venom toxoid by dihydrothioctic acid.
    Sawai Y; Kawamura Y; Fukuyama T; Okonogi T
    Jpn J Exp Med; 1969 Apr; 39(2):109-17. PubMed ID: 4904177
    [No Abstract]   [Full Text] [Related]  

  • 10. Snake and spider antivenin: risks and benefits of therapy.
    Weisman RS; Lizarralde SS; Thompson V
    J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051
    [No Abstract]   [Full Text] [Related]  

  • 11. Electric shock: a potentially hazardous approach to treating venomous snakebites.
    Gold BS
    Md Med J; 1993 Mar; 42(3):244-5. PubMed ID: 8350681
    [No Abstract]   [Full Text] [Related]  

  • 12. Snake bite and snake venoms.
    Warrell DA
    Q J Med; 1993 Jun; 86(6):351-3. PubMed ID: 8171181
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the improvement of treatment of Habu snake bite. I. Studies on the improvement of Habu snake antivenin.
    SAWAI Y; MAKINO M; MIYASAKI S; KATO K; ADACHI H; MITSUHASHI S; OKONOGI T
    Jpn J Exp Med; 1961 Apr; 31():137-50. PubMed ID: 13746937
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyvalent antivenin in treatment of experimental snake venom poisoning.
    MINTON SA
    Am J Trop Med Hyg; 1954 Nov; 3(6):1077-82. PubMed ID: 13207562
    [No Abstract]   [Full Text] [Related]  

  • 15. The improvement of the therapeutic anti-Lachesis muta serum production in horses.
    Stephano MA; Guidolin R; Higashi HG; Tambourgi DV; Sant'Anna OA
    Toxicon; 2005 Mar; 45(4):467-73. PubMed ID: 15733568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical laboratory: enzyme immunoassay for the rapid clinical identification of snake venom.
    Coulter AR; Harris RD; Sutherland SK
    Med J Aust; 1980 May; 1(9):433-5. PubMed ID: 6993892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time for an alternative perspective: the eternal problem of supply and quality of anti snake venom in the developing world--"it's the economy, stupid".
    Simpson ID
    Wilderness Environ Med; 2008; 19(3):186-94. PubMed ID: 18715131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Snake bites, lung damage and antivenins. Should Zagreb antivenin be used if the delay has exceeded 4 hours?].
    Børresen HC; Wagner K
    Tidsskr Nor Laegeforen; 1982 May; 102(15):840-2. PubMed ID: 7157260
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of inadequate antivenin stores on the medical treatment of crotalid envenomation.
    Dart RC; Duncan C; McNally J
    Vet Hum Toxicol; 1991 Jun; 33(3):267-9. PubMed ID: 1858308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.